Skip to content

Peer support for late presenters

A pilot study on the impact of peer support for people with advanced kidney failure presenting late to renal services

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN63482335
Enrollment
20
Registered
2023-04-19
Start date
2016-10-16
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Established kidney disease Urological and Genital Diseases

Interventions

Peer support (once weekly for four weeks) with standard care versus standard care alone. Standard Care: Standard care after starting dialysis without preparation inclu
who have had 5 hours of in-house training to help them have the necessary understanding of the expectations and barriers of the role and basic communication skills
and who are registered King’s College Hospital volunteers. Delivered one-to-one. The initial peer support session is face-to-face at King’s College Hospital Renal Unit
those who consented in months 7-12 received the intervention.

Sponsors

King's College Hospital NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years old 2. Commencing dialysis without preparation 3. Mental capacity to consent

Exclusion criteria

Exclusion criteria: 1. Lack of mental capacity 2. Acute kidney injury

Design outcomes

Primary

MeasureTime frame
Acceptability measured using semi-structured interviews, with thematic analysis, at the 3 months follow up

Secondary

MeasureTime frame
1. Biochemical/biological variables [blood pressure, Haemoglobin, potassium, phosphate, and calcium] measured using data recorded in the unit's database at baseline and 3-month follow-up 2. Treatment outcomes [dialysis modality, access, attendance/service use] measured using data recorded in the unit's database at 3-month follow-up 3. Patient-reported health-related quality of life outcomes measured using the EQ5D at baseline and 3 months 4. Patient activation measured using the Patient Activation Measure at baseline and 3 months

Countries

England, United Kingdom

Contacts

Public ContactEleri Wood
eleri.wood@nhs.net+44 (0)203 2996233

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026